Phase 2, Parallel???Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non???Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal???Epithelial Transition Factor
|Effective start/end date||9/1/15 → 3/14/18|
- MIRATI THERAPEUTICS, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.